CLINICAL_TRIALS ClinicalTrials.gov record update

Effects of a Glucagon-like Peptide-1 (GLP-1) Booster™ on Blood Glucose, HbA1c, Insulin, Glucagon, GLP-1, GIP, and Amylin Levels, Body Weight and Body Fat in Overweight Adult Men and Women

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07141472
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:22.849507+00:00
Published At: 2025-09-03T00:00:00+00:00
Record Updated At: 2025-09-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Blood Sugar; High", "Overweight and Obesity", "Fat Loss", "GLP-1", "Glucagon"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-03"
protocolSection.identificationModule.nctId: "NCT07141472"
protocolSection.identificationModule.officialTitle: "Effects of a Glucagon-like Peptide-1 (GLP-1) Booster\u2122 on Blood Glucose, HbA1c, Insulin, Glucagon, GLP-1, GIP, and Amylin Levels, Body Weight and Body Fat in Overweight Adult Men and Women"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.